Bone 2001: Vol 28 Index

10 Pages·2001·2.5 MB·English

Bone Vol. 28, No. 6
June 2001:662—664
ee Fes
ELSEVIER AUTHOR INDEX
Bone, Volume 28, 2001
Abramovitz, M., 275 Boyde, A., 237 Eastell, R., 108
Adams, C. S., | Brandstrom, H., 268 El Haj, A. J., 29, 603
Adams, J., 310 Breit, S., 182 Enokida, M., 87, 634
Adams, S. E., 54 Brixen, K., 454 Epstein, S., 583
Ahlborg, H., 118 Brommage, R., 150 Ethgen, D., 108
Ahlborg, H. G., 327 Bryer, H. P., 583 Evdokiou, A., 370
Ahonen, M., 423 Buckley, K. A., 507
Akhter, M. P., 414 Burr, D. B., 150, 524, 538
Faucheu, C., 491
Alhava, E., 123
Feldman, D., 319
Allain, P., 446 Feng, P., 14
Amizuka, N., 609 Cain, R. L., 538
Fernandez-Martinez, J. M., 316
Ammann, P., 446 Calikoglu, A. S., 410 Findlay, D. M., 370
Anderson, D., 104 Campagna, S., 113 Flanagan, A. M., 577
Anderson, R. J., 617 Canalis, E., 484 Flyvbjerg, A., 341
Antoine, E., 54 Candeliere, G. A., 351
Forwood, M. R., 524
Appleyard, R., 80 Caulin, F., 440
Foundation, P. D. DC S AIO, 575
Ardizzoni, A., 215 Caverzasio, J., 589
Franci, B., 113
Aro, H. T., 423 Chae, H. J., 45
Francis, R., 310
Atfi, A., 491 Chae, S. W., 45
Frost, A., 268
Athanasou, N. A., 261 Chalhoub, N., 513 Frydenberg, M., 556
Atkins, G. J., 370 Chang, J. Y., 45
Fuchs, T., 341
Aubin, J. E., 351 Chappard, D., 72
Fujie, K., 332
Audran, M., 72 Chennebault, A., 72 Fujikawa, Y., 261
Augat, P., 133 Chin, H. Y., 45
Fukunaga, T., 404
Cho, S. B., 45
Fyhrie, D. P., 195
Christgau, S., 461
Bail, H., 341 Christiansen, C., 446
Gallagher, J. A., 507
Balint, E., 21 Claes, L. E., 133
Gallea, S., 491
Balkan, W., 38, 362 Coleman, N., 65
Bang, B. G., 45 Collette, J., 108 Garnero, P., 461
Gartland, A., 507
Banse, X., 563 Collin, P., 9
Gasser, J. A., 237
Banu, J., 202 Compston, J. E., 65
Geary, S. M., 370
Bao, J. Y., 94 Cornu, O., 563
Gentz, R., 14 .
Bardelay, C., 54 Cullen, D. M., 251
Ghivizzani, S. C., 499 :
Baron, R., 54, 491, 513
Bartlett, C., 54 Gibson, G. J., 195
Basle, M. F., 72 Dahl, S. G., 446 Giovani, S., 113
Benachenhou, N., 513 Dai, J., 167 Glas, H., 94
Beneton, M., 310 Dalgarno, D. C., 54 Goodman, G. R., 583
Gowen, M., 282, 532
Benford, H. L., 465 Dare, L. C., 532
Graves, S. E., 174, 370
Bernard, J., 310 Davies, M., 310
Bezooijen, R. L., 378 de Takats, D., 310 Gronthos, S., 174
Grynpas, M., 563
Bilbe, G., 507 Dearden, R. L., 220
Gu, Y., 29
Black, A., 295 Deckers, M. M. L., 14
Blay, P., 316 Delany, A. M., 484 Guan, W., 54
Blind, E., 182 Delloye, C., 563 Gunther, D. F., 410
Bohacek, R. S., 54 Delmas, P. D., 446, 461, 575
Boivin, G., 446 Devogelaer, J. P., 563 Haas, N. P., 341
Boldsen, J. L., 454 Diamandis, A., 319 Hagino, H., 87, 634
Bolotin, H. H., 548 Diamond, T., 80 Hall, C. M., 617
Bonjour, J. P., 589 Diaz-Lépez, B., 316 Han, K. S., 45
Bord, S., 65 D’I ppolito, G., 38, 362 Handa, H., 332
Bosch, P., 499 Dissanayake, I. R., 583 Handy, A. M., 295
Bosel, J., 182 Diwan, A. D., 80 Hao Lin, J., 80
Boskey, A. L., 387 Dodds, R. A., 282 Harada, S., 275
Bouffard, E., 14 Doty, S., 387 Hasserius, R., 440
Bouralexis, S., 370 Drake, F. H., 282 Hauge, E. M., 556
Bowler, W. B., 507 Duan, Y., 118 Hay, S., 370
Bowman, A. R., 583 Dubin, R. L., 617 Haynes, D. R., 370
© 2001 by Elsevier Science Inc. 8756-3282/01/$20.00
All rights reserved.
Bone Vol. 28, No. 6 Author Index 663
June 2001:662—664
Heersche, J. N. M., 187 Kim, D. E., 45 Merregaert, J., 14
Heiskanen, J. T., 123 Kim, H. H., 45 Mistry, J., 319
Helfrich, M. H., 465 Kim, H. M., 45 Miyanishi, K., 641
Hipskind, R. A., 507 Kim, H. R., 45 Morales-Piga, A., 104
Hirano, T., 524 Kim, S. C., 45 Moreau, M., 72
Hock, J. M., 150, 538 Kimmel, D. B., 251 Morio, Y., 87
Hocking, L., 104 Kimura, J., 195 Mosekilde, L., 556
Hoffman, S. J., 532 Kinoshita, T., 290 Munting, E., 563
Hogan, J. J., 430 Kinzl, L., 133 Murrell, G. A. C., 80
Holm, I. A., 430 Kneissel, M., 237 Musgrave, D. S., 499
Holmes, S., 282 Kobashi, N., 404
Homminga, J., 650 Kohashi, O., 474 Nakajima, T., 609
Honjo, T., 145 Komine, M., 474 Nakamura, T., 625
Horiuchi, H., 290 Krischak, G. D., 133 Namkung-Matthai, H., 80
Horner, A., 65 Kroger, H., 123 Neale, S. D., 261
Horton, M. A., 577 Kudlacek, P. E., 617 Neff, L., 513
Hotokebuchi, T., 474 Kukita, A., 474 Nelson, A. E., 430
Howard, G. A., 38, 362 Kukita, T., 474 Neu, C. M., 227
Howl, J. D., 29 Ni, J., 14
Hsieh, A. S., 94 Lallemand, F., 491 Nielsen, L. B., 160
Huard, J., 499 Lamberg-Allardt, C., 123 Nilsson, B. E., 327
Huet, L., 491 Lane, M. A., 295 Nilsson, O., 268
Hughes, A., 104 Lark, M. W., 282 Nishida, S., 625
Huiskes, R., 650 Lechowska, B. A., 532 Nishihira, J., 332
Hwang, S. M., 282 Lee, K. H., 45 Nuti, R., 113
Lee, S. J., 45 Nuttall, M. E., 465
lizuka, T., 332 Lee, Y. M., 45
Ikeda, S., 625 Lee, Z. H., 45 Obrant, K. J., 118
Im, M. K., 45 Lees, R. L., 187 O’Brien, E. A., 208
Ingram, D. K., 295 Legrand, E., 72 Oden, A., 440
Irisa, T., 641 Leis, H. J., 595 Ogata, Y., 474
Ito, M., 609, 625 Lesuisse, D., 54 Okano, T., 87, 634
Itonaga, I., 261 Li, X-Y., 617 Orhii, P. B., 202
Iwamoto, Y., 641 Liang, H., 220 Ozaki, M., 332
Iwaniec, U. T., 251 Liu, F., 351 Ozawa, H., 609
Ljunggren, O., 268
Jacobsen, B. K., 655 Ljunghall, S., 268 Paakkonen, M., 123
Jacobsen, V. A., 54 Lomri, A., 9 Palmer, G., 589
Jalava, T., 310 Lowik, C. W. G. M., 14, 378 Pande, K., 310
James, I. E., 282 Loyttyniemi, E., 310 Papapoulos, S. E., 378
Jamsa, T., 423 Lucke, M., 341 Parmelee, D., 14
Jansen, J., 80 Lynch, B. A., 54 Parviainen, M. T., 123
Jee, W. S. S., 583 Paschalis, E. P., 387
Jenkins, E. L., 532 Ma, Y., 583 Pedersen, F. S., 160
Jeppsson, S., 327 Maastricht, S., 80 Pedersen, L., 160
Jerome, C. P., 150 Macek, K. J., 54 Pereira, R. M. R., 484
John, M. R., 182 Machwate, M., 275 Pileri, C. L., 617
Johnell, O., 118, 327, 440 Magnay, J. L., 603 Plenk, H., Jr., 94
Johnson, M. L., 617 Magnusson, H., 128 Poulsen, L. W., 454
Johnston, C. C., 524 Mandine, E., 54 Preston, M. R., 29, 603
Jonsson, K. B., 268 Mansfield, K., 1 Pruchnic, R., 499
Jgérgensen, L., 655 Manz, F., 227 Publicover, S. J., 29
Marie, P. J., 9, 446 Pun, S., 220, 583
Kahari, V.-M., 423 Marshall, C. F., 21
Kalu, D. N., 202 Marshall, M. J., 208 Qvesel, D., 454
Kamioka, H., 145 Martini, G., 113
Kanis, J. A., 310, 440 Mashiba, T., 524, 538 Rajapurohitam, V., 513
Karlsson, C., 128 Mason, R. S., 80, 430 Ralston, S., 104
Karlsson, M. K., 118, 128, 327 Massey, H. M., 577 Ramez, V., 491
Karperien, M., 14 Mauras, Y., 446 Rannevik, G., 327
Kawai, S., 491 McCloskey, E., 310 Rantakokko, J., 423
Keller, E. T., 167 McClung, H. A., 282 Raschke, M., 341
Kelsall, A. W., 65 McGowan, N. W. A., 465 Ratkus, A. M., 220
Khan, M., 387 Melsen, F., 556 Rauch, F., 227
Khosravi, J., 319 Mentzel, M., 133 Rawadi, G., 491
Khoury, J. L., 195 Merkel, A., 227 Recker, R. R., 251, 414
664 Author Index Bone Vol. 28, No. 6
June 2001:662-—664
Redlund-Johnell, I., 440 Smith, J. A., 54 Van Schravendijk, M. R., 54
Reginster, J.-Y., 108 Smits, P., 14 Van Wesenbeeck, L., 104
Rickles, R. J., 54 Spinella-Jaegle, S., 491 Vanhoenacker, F., 104
Rieman, D. J., 282 Sprague, S. M., 21 Vashishth, D., 195
Robbins, P. D., 499 Srisawasdi, S., 387 Vasko-Moser, J. A., 532
Robey, P. G., 174 Stemberger, A., 341 Verbruggen, L., 104
Robinson, B. G., 430 Stiner, D., 387 Vesterby, A., 454
Robinson, J., 310 Stroup, G. B., 532 Violette, S. M., 54
Rodan, G. A., 275 Sueishi, K., 641 Vuorio, E., 423
Rogers, M. J., 465 Sugioka, Y., 641
Roman-Roman, S., 491 Sun, H. B., 303, 399 Wachter, N. J., 133
Roos, B. A., 38, 362 Suzuki, A., 589 Wakabayashi, S., 290
Roth, G. S., 295 Swain, M., 80 Walker, L. M., 603
Roumagnac, I., 108 Swami, S., 319 Wang, L., 202
Russell, R. G. G., 108 Szabo, P., 21 Weigele, M., 54
Weinreb, M., 275
Tae, K. C., 45 Westhovens, R., 104
Sabharwal, V. K., 187
Wickert, H., 182
Takano- Yamamoto, T., 145, 404
Sabokbar, A., 261
Takaoka, K., 290 Wildemann, B., 341
Saito, N., 290
Williams, J. H. H., 208
Takeda, S., 625
Sakai, A., 625
Takeuchi, C. S., 54 Windischhofer, W., 595
Sakamoto, W., 332
Winet, H., 94
Tanck, E., 650
Sakata, T., 625
Wright, V., 499
Teixeira, C. C., 1
Samnegard, E., 251, 414
Wronski, T. J., 220
Teshima, R., 87, 634
Sarabia, S. F., 319
Wuyts, W., 104
Thomas, P. B. M., 603
Sarkar, M. R., 133
Tilmont, E. M., 295
Sato, M., 538 Yamamoto, T., 641
Torisu, T., 261
Sawyer, T. K., 54
Yamasaki, D., 87, 634
Tsouderos, Y., 446
Schaffler, M. B., 195
Yamashiro, T., 404
Tsurukami, H., 625
Schiller, P. C., 38, 362
Yamashita, A., 641
Tsutsumimoto, T., 290
Schmidmaier, G., 341 Yamashita, K., 404
Turner, C. H., 524, 538
Schoenau, E., 227 Yamauchi, M., 387
Scopes, J., 577 Tuukkanen, J., 423 Yang, M., 54
Tylzanowski, P., 14
Scott, W. W., 295 Yao, Z., 167
Seeman, E., 118, 128 Yee, J. A., 617
Selby, P., 310 Underwood, L. E., 410
Yokota, H., 303, 399
Sernbo, I., 440 Uusitalo, H., 423 Yukawa, S., 332
Shakespeare, W. C., 54
Shapiro, I. M., 1 Vacher, J., 513 Zach, D., 595
Shapses, S. A., 295 Valenti, R., 113 Zannettino, A. C. W., 370
Shir, N., 275 Van Bibber, T., 150 Zegels, B., 108
Shiraishi, A., 625 Van Hul, W., 104 Zhang, J., 14, 167
Simmons, P. J., 174 van Lenthe, G. H., 650 Ziegler, R., 182
Bone Vol. 28, No. 6
June 2001:665—670
4 > {)
ELSEVIER
SUBJECT INDEX
Bone, Volume 28, 2001
Acid phosphatase Collagen-induced, tibial/vertebral bone Bone morphogenetic protein-2-induced,
Bone marker nomenclature mass changes and, 87 pentoxifylline enhancement of, 290
recommendations and, 575 Matrix metalloproteinase-13 mRNA Cortisol inhibition of osteoblast
Adenosine triphosphate level in synovial cells, mechanical differentiation and apoptosis and,
Bone remodeling and, 507 loading effects, 399 484
Adolescents Asthma Ectopic, bone morphogenetic protein-2
Bone density and bone size evaluation, Cyclosporine A-induced bone loss and, effects, 499
peripheral quantitative computed transforming growth factor-8 effects, Glucose effects on, 21
tomography, 227 593 Inorganic phosphate transporters and,
Age 160
Bone mineral density analysis by Bone growth
Biomechanics
quantitative ultrasound and, 118 Architectural adaptation, bone volume
Nonenzymatic glycation influence on
Aging fraction increase and, 650
cortical bone, 195
Bone loss related to, male and Vascular endothelial growth factor
Biomineralization
premenopausal female primate inhibition of, 65
Gap-junctional communication effects
Bone healing
model, 295
on osteoblast cell maturation, 362
Femur, metaphyseal defect model for
Alcoholism
Biosynthesis
study of, 423
Bone loss and fractures, nuclear factor-
Cathepsin K, in osteoclasts, 282
Bone histomorphometry
KB and, 167
Bisphosphonates
Type II errors in research studies,
Alkaline phosphatase
Bone turnover suppression by,
avoidance of, 556
Bone marker nomenclature microdamage accumulation and, 524
Bone inflammation
recommendations and, 575 Caspase-3 activity and, visualization in
Hyperphosphatemic tumoral calcinosis,
Extracellular matrix protein | gene apoptotic osteoclasts, 465
vertebral involvement in, 316
effects on, 14 Osteoclasts effects, in osteosclerosis,
Bone loss
Androgen 609
Age-related, male and premenopausal
Bone maturation acceleration, Faslodex Body composition
female primate model, 295
effects, 410 Insulin-like growth factor-1 and leptin
Cyclosporine A-induced, transforming
Angiogenesis influence on bone mass and,
growth factor-8 effects, 593
Vascular endothelial growth factor role postmenopausal women, 113
Ethanol-mediated, nuclear factor-kB
in bone growth and, 65 Bone
role in, 167
Angiopoietin Bone-derived neurotrophic factor gene
Menopause and, long-term prospective
Bone growth and, 65 and protein expression in, 404
study, 327
Cathepsin K biosynthesis and
Anisotropy
Osteoclast size relation to, 187
Trabecular architecture in growing processing, 282
Bone markers
bone, bone volume fraction increase Fracture healing, osteoporosis effects
Standard nomenclature for, 575
on, rats, 80
effects, 650
Bone marrow
Giant cell tumors of, osteoprotegerin
Antiresorptive therapy
Fatty sites, basic fibroblast growth
inhibition of bone
Dual-energy x-ray absorptiometry
factor levels at, ovariectomized rats,
resorption/osteoclast formation in,
inaccuracies of BMD effects on
220
370
osteopenia/osteoporosis evaluation,
Bone mass
Paget’s disease of, RANK and OPG
548
Changes, collagen-induced arthritis
gene role, 104
Estrogen and gonadotropin-releasing
and, 87
Serine-485-to-alanine mutation in
hormone effects on bone turnover Insulin-like growth factor-1 and leptin
parathyroid hormone receptor and,
and, cynomolgus monkeys, 532 influence, postmenopausal women,
182
Apoptosis Strontium incorporation and 113
Chondrocyte, mediation by phosphate distribution in, 446 Parathyroid hormone effects on,
ions, | Bone collagen rabbits, 538
Osteoblasts, cortisol inhibition of, 484 Nonenzymatic glycation influence on, Vertebral body, parathyroid hormone
Osteoclasts, bisphosphonate effects on, 195 maintenance of, ovariectomized rats,
in osteosclerosis, 609 Bone development 414
Archeology Insulin-like growth factor-1 and leptin Bone mass density
Bone mineral density in medieval influence on, 113 Exercise duration as regulator of, 128
women, multiparity and, 454 Vascular endothelial growth factor Bone maturation
Arthritis inhibition of, 65 Androgen-accelerated, Faslodex
Collagen-induced, ovariectomy and Bone formation effects, 410
estrogen replacement therapy effects Basic fibroblast growth factor levels at Bone metabolism
in, 632 fatty marrow sites and, 220 Coffee consumption effects on, 332
© 2001 by Elsevier Science Inc. 665 8756-3282/01/$20.00
All rights reserved.
666 Subject Index Bone Vol. 28, No. 6
June 2001:665—670
Bone mineral density (BMD) Bone strength Chondrocytes
After total gastrectomy, 123 Peripheral quantitative computed Apoptosis of, mediation by phosphate
Botulism toxin-related loss, x-ray tomography predictive value, 133 ions, |
analysis, 72 Vertebral body, parathyroid hormone Bone-derived neurotrophic factor gene
Changes after stroke, 655 maintenance of, ovariectomized rats, and protein expression in bone and
Collagen-induced arthritis effects on 414 cartilage, 404
bone mass, 87 Bone structure Clodronate
Dual-energy x-ray absorptiometry Long-term parathyroid hormone Vertebral fracture risk in osteoporosis
analysis, comparison with treatment effects, 237 and, l-year analysis, 310
quantitative ultrasound, 118 Bone tissue Clostridium botulinum
Dual-energy x-ray absorptiometry Prostaglandin E expression in, rats, Osteoporosis related to, x-ray analysis,
inaccuracies effects on osteopenia/ Rig 72
osteoporosis evaluation, 548 Bone turnover Coffee consumption
Bone metabolism effects, 332
Hormone replacement therapy targeting Bisphosphonate-induced suppression,
Collagen
after menopause, 440 microdamage accumulation and,
Arthritis induced by, tibial/vertebral
In medieval women, multiparity and, canines, 524
bone mass changes and, 87
454 Extracellular nucleotide signaling role
Type I, bone marker nomenclature
Menopause and, long-term prospective
in activation, 507
recommendations and, 575
study, 327
Gonadotropin-releasing hormone and
Type II, breakdown of, zoledronate
Ovariectomy and estrogen replacement
estrogen effects, cynomolgus
effects in Paget’s disease, 461
therapy effects, rats, 634
monkeys, 532
Computed tomography, peripheral
Peripheral quantitative computed
Long-term parathyroid hormone
quantitative
tomography analysis, children and
treatment effects, 237
Bone density and bone size analysis,
adolescents, 227
Bone volume children and adolescents, 227
Predictive value of peripheral
Parathyroid hormone effects, 150 Bone healing studies, 423
quantitative computed tomography,
Botulism Bone mineral density predictive value,
133
Bone mineral density loss and, x-ray 133
Bone mineral metabolism
analysis, 72 Growth hormone/parathyroid hormone
After total gastrectomy, 123
effects on bone loss, 202
Bone mineralization
Calcinosis Confocal laser scanning microscopy
Chondrocyte-mediated, homocysteine
Hyperphosphatemic tumoral, vertebral Osteocytes process distribution
effects on, 387
involvement in, 316 analysis, 145
Long-term parathyroid hormone
Calcium Cortical bone
treatment effects, 237
Coffee consumption effects on bone Biomechanical properties of,
Strontium distribution and, 446
metabolism and, 332 nonenzymatic glycation influence
Bone morphogenetic protein-2
Calcium deposition on, 195
Bone formation induced by,
Osteoblastic, glucose effects on, 21 Maintenance of, parathyroid hormone-
pentoxifylline enhancement of, 290
Calvaria treated ovariectomized rats, 251
Osteoblastic differentiation of C2C12
Mechanical properties, parathyroid
Developing, osteoblast expression of
cells, 491
hormone effects on, rabbits, 538
gene repertoires in, 351
Skeletal muscle-derived cell fate
Reperfusion of, crush injury ischemia
Cancellous bone
effects, 499
duration and, 94
Strength of, peripheral quantitative
Bone quality
Cortisol
computed tomography predictive
Vertebral cancellous bone, density and
Osteoblast differentiation and apoptosis
value, 133
structure patterns of, 563
inhibition and, 484
Vertebral, density and structure
Bone remodeling Crush injury
patterns of, 563
Extracellular nucleotide signaling role Bone, ischemia duration effects on
Volume of, parathyroid hormone
in activation, 507 reperfusion in cortical bone, 94
effects, 150
Parathyroid hormone effects on, Cyclosporine A
rabbits, 538 Cartilage Bone loss induced by, transforming
Bone resorption Bone-derived neurotrophic factor gene growth factor-B effects, 593
Macrophage-colony stimulating factor and protein expression in, 404 Cytokines
effects on, 261 Replacement, vascular endothelial Coffee consumption effects on bone
Osteoclast size relation to, 187 growth factor inhibition and, 65 metabolism and, 332
Osteoclastic, IL-17 effects on, 378 Caspase-3
Osteoprotegerin inhibition of in giant Bisphosphonate-induced activity,
cell tumors of bone, 370 visualization in apoptotic osteoclasts, Deoxypyridinoline
Sre role in, 54 465 Bone marker nomenclature
Bone sialoprotein Cathepsin K recommendations and, 575
Bone marker nomenclature Biosynthesis and processing in Coffee consumption effects on bone
recommendations and, 575 osteoclasts, 282 metabolism and, 332
Bone size Children Differential interference contrast
Peripheral quantitative computed Bone density and bone size evaluation, microscopy
tomography analysis, children and peripheral quantitative computed Osteocytes process distribution
adolescents, 227 tomography, 227 analysis, 145
Bone Vol. 28, No. 6 Subject Index 667
June 2001:665—670
DT-diaphorase Vertebral, risk in osteoporosis, Hypophosphatemia
Expression and activity in osteoblastic clodronate effects, 310 Oncogenic osteomalacia and, 430
cells, 9 Fracture healing
Dual-energy x-ray absorptiometry Insulin-like growth
Immunohistochemistry
Age-related bone loss, male and factor-1/transforming growth factor-
Bone-derived neurotrophic factor gene
premenopausal female primate B1 effects on, rats, 341
and protein expression in bone and
model, 295 Peripheral quantitative computed
cartilage, 404
tomography for study of, 423
Indomethacin
Embryo Osteoclast inhibition role,
Metatarsals, extracellular matrix (-Galactosidase osteoprotegerin effects, 208
protein | gene effects on, 14 Bone morphogenetic protein-2 effects Inflammatory bowel disease
Endothelin on muscle regeneration and, 499 Cyclosporine A-induced bone loss and,
Prostaglandin release and, 595 Gap-junctional communication transforming growth factor-B effects,
Enzyme-linked immunosorbent assay Osteoblast cell maturation and, 362 593
Vitamin D receptor measurement, 319 Gastrectomy Insulin-like growth factor-1
Epinephrine Bone mineral density after, 123 Bone mass effects, postmenopausal
Inorganic phosphate transport and, 589 Gender women, 113
17B-Estradiol Bone mineral density analysis by Fracture healing effects, rats, 341
Cortical bone maintenance after quantitative ultrasound and, 118 Integrin
ovariectomy and, rats, 251 Genetic studies Bone marrow stromal cells and
Estrogen Paget’s disease of bone, RANK and extracellular matrix interactions, 174
Bone turnover effects, cynomolgus OPG gene role, 104 Interleukin-1
monkeys, 532 Glucocorticoids Osteoclast formation and, 261
Phenol sulfotransferases in osteoblasts Osteoblast differentiation and apoptosis Interleukin-3
and osteosarcoma and, 617 inhibition and, 484 Osteoclast formation and, 261
Estrogen deficiency Glucose Interleukin-6
Osteoporosis effects on fracture Bone formation and osteoblast Stimulation of, in osteoblasts, 268
healing and, rats, 80 maturation effects, 21 TNF-a induction, p38 mitogen-
Estrogen replacement therapy Glycation activated protein kinase effects, 45
Arthritis and bone mineral density Nonenzymatic, cortical bone Interleukin-13
effects after, rats, 634 biomechanical properties and, 195 Proliferation in osteoblasts and, 268
Ethanol Gonadotropin-releasing hormone Interleukin-17
Bone loss mediated by, nuclear factor- Bone turnover effects, cynomolgus Nitric oxide production and bone
KB role in, 167 monkeys, 532 resorption effects, 378
Exercise Granulocyte macrophage-colony Ion channels
Duration of, bone mass density stimulating factor Osteocytes effects on mineral
regulation and, 128 Osteoclast formation and, 261 homeostasis and
Extracellular matrix Growth hormone mechanotransduction and, 29
Bone marrow stromal cells and, Lumbar vertebral bone effects, Ischemia
integrin-mediated interactions, 174 osteopenic rats, 202 Crush injury, duration of, reperfusion
in cortical bone and, 94
Mineralization of, parathyroid hormone
role, gap-junctional intercellular
Histomorphometry
communication and, 38 Lamellar thickness
Bone, type II errors in research studies,
Extracellular matrix protein 1 gene Osteocyte lacunae and, in secondary
avoidance of, 556
Alkaline phosphatase activity and osteons, 215
Collagen-induced arthritis effects on
mineralization effects, 14 Leptin
bone mass, 87
Bone mass effects, postmenopausal
History
women, 113
Faslodex Bone mineral density in medieval
Limb ischemia
Androgen-accelerated bone maturation women, 454
Duration, cortical bone reperfusion
and, 410 Homocysteine
and, 94
Fat mass Chondrocyte-mediated bone
Lipopolysaccharide
Changes after stroke, 655 mineralization effects, 387
Osteonecrosis induced by, rabbits, 641
Femoral neck Hormone replacement therapy
Lumbar vertebra
Fracture, osteoporosis effects on, rats, Targeting after menopause, 440
Bone loss associated with ovariectomy,
80 Hydroxylysine
growth hormone/parathyroid
Fibroblast growth factor, basic Bone marker nomenclature
hormone effects on, 202
Levels at fatty marrow sites, recommendations and, 575
Strength, after bilateral ovariectomy,
ovariectomized rats, 220 Hydroxyproline
trabecular bone contour effects, 625
Fracture Bone marker nomenclature
Fragility, bone mineral density analysis recommendations and, 575
by quantitative ultrasound, 118 Hypercoagulability Macrophage-colony stimulating factor
Healing, osteoporosis effects in early Lipopolysaccharide-induced Osteoclast formation and, 261
period, rats, 80 osteonecrosis and, rabbits, 641 Matrix metalloproteinase
Hormone replacement therapy targeting Hyperphosphatemic tumoral calcinosis mRNA levels in rheumatoid arthritis,
after menopause, 440 Vertebral involvement in, 316 303
668 Subject Index Bone Vol. 28, No. 6
June 2001:665—670
Matrix metalloproteinase-13 Neurotrophic factor Maturation/function, malignant
mRNA level in synovial cells, Bone-derived, gene and protein osteopetrosis and, 513
mechanical loading effects, 399 expression in bone and cartilage, Peripheral blood hematopoietic
Mechanical loading 404 precursors and, transforming growth
Matrix metalloproteinase-13 mRNA Nicotine factor-B1 stimulation of, 577
level in synovial cells and, 399 Cellular level effects, postmenopausal Resorption, Src activity inhibition and,
Mechanical properties osteoporosis and, 603 54
Cortical bone, nonenzymatic glycation Nitric oxide production Size of, relation to bone resorption
IL-17 effects on, 378 efficiency, 187
influence on, 195
Nuclear factor-«KB Osteocyte lacunae
Mechanotransduction
Bone loss in alcoholics and, 167 Lamellar thickness and, in secondary
Osteocytes effects, ion channels and,
Tumor necrosis factor-a and, stromal osteons, 215
29
cell depletion in bone marrow and, Osteocytes
Menopause
474 Mineral homeostasis and
Bone loss and, long-term prospective
mechanotransduction, ion channels
study, 327
role, 29
Hormone replacement therapy targeting
Oncogenic osteomalacia Processes of, confocal laser scanning
after, 440
Phosphate wasting in, 430 and differential interference contrast
Mesenchymal cell micro-mass cultures
OPG gene microscopy analysis, 145
Homocysteine effects on chondrocyte-
Paget’s disease of bone and, 104 Osteogenesis
mediated bone mineralization and,
Ossification Endothelin and sarafotoxin effects on
387
Endochondrial, vascular endothelial prostaglandin release and, 595
Metatarsals
growth factor inhibition of, 65 Osteomalacia
Embryonic, extracellular matrix protein
Osteoblasts Oncogenic, phosphate wasting in, 430
1 gene effects on, 14
In developing calvaria, gene expression Osteonecrosis
Microdamage accumulation and, 351 Lipopolysaccharide-induced, rabbits,
Bisphosphonate-induced suppression of Differentiation, C2C12 cells, bone 641
bone turnover and, 524 morphogenetic protein-2 effects, 491 Osteons
Microscopy Differentiation and apoptosis of, Osteocyte lacunar size-lamellar
Confocal laser scanning and cortisol inhibition of, 484 thickness relations in, 215
differential interference contrast, Differentiation of, inorganic phosphate Osteopenia
osteocytes process distribution transport and, 160 Dual-energy x-ray absorptiometry
analysis, 145 IL-13 and IL-4 inhibition of inaccuracies of BMD effects
Mineral homeostasis proliferation in, 268 evaluation of, 548
Osteocytes effects, ion channels and, Inorganic phosphate transporters and, Glucose effects on bone formation and,
29 160 21
Mineralization Maturation, glucose effects on, 21 Lumbar vertebral bone, growth
Extracellular matrix, parathyroid Maturation of, gap-junctional hormone/parathyroid hormone
hormone role, gap-junctional communication and, 362 effects, 202
intercellular communication and, 38 NAD(P)H:quinone oxidoreductase Osteopetrosis
Extracellular matrix protein 1 gene expression and activity in, 9 Malignant, osteoclast maturation and
effects on, 14 Parathyroid hormone-stimulated function and, 513
mineralization in, gap-junctional Src role in bone resorption, 54
Mitogen-activated protein kinase
intercellular communication and, 38 Osteoporosis
Osteoblast differentiation of C2C12
Phenol sulfotransferases in, 617 After stroke, l-year prospective study,
cells, bone morphogenetic protein-2
Prostaglandin E expression in, rats, 655
effects, 491
275 Disuse, botulism toxin-related, x-ray
Multiparity
Osteocalcin analysis, 72
Bone mineral density in medieval
Bone marker nomenclature Dual-energy x-ray absorptiometry
women, 454
recommendations and, 575 inaccuracies of BMD effects
Muscle mass
Coffee consumption effects on bone evaluation of, 548
Changes after stroke, 655
metabolism and, 332 Fracture healing effects, rats, 80
Muscle regeneration
Osteoclasts High-dose risedronate safety,
Bone morphogenetic protein-2 effects
Apoptotic, bisphosphonate-induced postmenopausal women, 108
on muscle-derived cells, 499
activity caspase-3 and, 465 Menopause and, long-term prospective
Muscle-derived cells
Cathepsin K biosynthesis and study, 327
Bone morphogenetic protein-2 effects
processing in, 282 Postmenopausal
on, 499
Coffee consumption effects on bone parathyroid hormone treatment
metabolism and, 332 effects, 150
NAD(P)H:quinone oxidoreductase Formation, macrophage-colony smoking effects at cellular level and,
Expression and activity in osteoblastic stimulating factor and humoral 603
cells, 9 factors effects on, 261 Serine-485-to-alanine mutation in
Nephrotic syndrome Formation, osteoprotegerin inhibition parathyroid hormone receptor and,
Cyclosporine A-induced bone loss and, of in giant cell tumors of bone, 370 182
transforming growth factor-B effects, Inhibition by indomethacin, Strontium distribution in bone and, 446
593 osteoprotegerin effects, 208 Total gastrectomy and, 123
Bone Vol. 28, No. 6 Subject Index 669
June 2001:665—670
Vertebral cancellous bone, density and Phenol sulfotransferases Serine-485-to-alanine mutation
structure patterns of, 563 In osteoblasts and osteosarcoma, 617 In parathyroid hormone receptor, 182
Vertebral fracture risk in, clodronate Phosphate SH2 domain
effects, 310 Wasting, in oncogenic osteomalacia, Src activity inhibition and osteoclast
Osteoprotegerin 430 resorption, 54
Bone resorption/osteoclast formation Phosphate, inorganic Skeletal tissue
inhibition, in giant cell tumors of Transport Nicotine effects at cellular level, 603
bone, 370 epinephrine effects, 589 Smoking
Indomethacin-induced osteoclast osteoblast differentiation and, 160 Cellular level effects, postmenopausal
inhibition and, 208 Phosphate ions osteoporosis and, 603
Osteoprotegerin gene Chondrocyte apoptosis mediation and, Src activity
Paget’s disease of bone and, 104 l Inhibition, osteoclast resorption and, 54
Osteosarcoma Polymorphism Stroke
Phenol sulfotransferases in, 617 Paget’s disease of bone, RANK and Muscle mass, fat mass, and bone
Osteosclerosis OPG gene role in, 104 mineral density after, 655
Bisphosphonate effects on osteoclasts Proliferation Stromal cells
in, 609 DT-diaphorase expression and activity Depletion in bone marrow, TNF-a and
Ovariectomy in osteoblastic cells and, 9 NF-«B and, 474
Arthritis and bone mineral density Prostaglandin Development, interaction with
effects after, rats, 634 Osteoclast inhibition by indomethacin extracellular matrix, 174
Basic fibroblast growth factor levels at and, 208 Strontium
fatty marrow sites and, 220 Prostaglandin E Bone distribution of, 446
Bilateral, trabecular bone contour Expression in osteoblasts and bone Sulfation
effects on lumbar vertebra strength tissue, rats, 275 Phenol sulfotransferases in osteoblasts
after, 625 Prostaglandin release and osteosarcoma and, 617
Bone loss associated with, growth Endothelin and sarafotoxin effects, 595 Sulfotransferase
hormone/parathyroid hormone Protein tyrosine kinase In osteoblasts and osteosarcoma, 617
effects on, 202 Ethanol-mediated bone loss and, 167 Synovial cells
Pyridinoline Matrix metalloproteinase-13 mRNA
Bone marker nomenclature level in, mechanical loading effects,
P38 mitogen-activated protein kinase recommendations and, 575 399
Tumor necrosis factor-a induction of
interleukin-6 and, 45 Quiescence Telopeptides
Paget’s disease of bone DT-diaphorase expression and activity Bone marker nomenclature
RANK and OPG genes role in, 104 in osteoblastic cells and, 9 recommendations and, 575
Zoledronate effects on type II collagen Texture analysis
breakdown, 461 Radius Botulism toxin-related osteoporosis
Parathyroid hormone Size of, peripheral quantitative and, x-ray analysis, 72
Bone mass, remodeling and cortical computed tomography analysis, Thyroid hormones
bone mechanical properties, rabbits, children and adolescents, 227 Phenol sulfotransferases in osteoblasts
538 RANK gene and osteosarcoma and, 617
Bone remodeling and, 507 Paget’s disease of bone and, 104 Trabecular architecture
Cortical bone maintenance after Reperfusion injury Growing bone and, bone volume
ovariectomy, rats, 251 In cortical bone, crush injury ischemia fraction increase effects, 650
Extracellular matrix mineralization, duration and, 94 Trabecular bone
gap-junctional intercellular Research Contour, lumbar vertebra strength after
communication and, 38 Bone histomorphometry, type II errors bilateral ovariectomy and, 625
Long-term treatment, bone structure/ in research studies, avoidance of, Transcription factor
mineralization effects, 237 556 mRNA levels in rheumatoid arthritis
Lumbar vertebral bone effects, Rheumatoid arthritis and, 303
osteopenic rats, 202 Bone mass changes induced by, 87 Transforming growth factor-B
Postmenopausal osteoporosis effects, Cyclosporine A-induced bone loss and, Cyclosporine A-induced bone loss and,
150 transforming growth factor-8 effects, 593
Vertebral body bone mass 593 Transforming growth factor-B1
maintenance, ovariectomized rats, Matrix metalloproteinase, Fracture healing effects, rats, 341
414 metalloproteinase tissue inhibitors, Stimulation of osteoclast-forming
Parathyroid hormone receptor and transcription factor mRNA potential of peripheral blood
Serine-485-to-alanine mutation in, 182 levels in, 303 hematopoietic precursors, 577
Pentoxifylline Risedronate Transplantation
Bone formation induced by bone Cortical bone maintenance after Bone loss after, transforming growth
morphogenetic protein-2 and, 290 ovariectomy and, rats, 251 factor-B effects, 593
Peripheral blood hematopoietic High-dosage, safety, in postmenopausal Tumor
precursors women, 108 Giant cell, of bone, osteoprotegerin
Osteoclast-forming potential of, inhibition of bone
transforming growth factor-B 1 Sarafotoxin resorption/osteoclast formation in,
stimulation of, 577 Prostaglandin release and, 595 370
670 Subject Index Bone Vol. 28, No. 6
June 2001:665—670
Tumor necrosis factor-a Exercise duration and bone mass Osteoporosis and, long-term
Interleukin-6 induction, p38 mitogen- regulation, 128 prospective study, 327
activated protein kinase effects, 45 Osteoporotic, risedronate effects on
NF-«B and, stromal cell depletion in Vascular endothelial growth factor parathyroid hormone levels and
bone marrow and, 474 Bone growth and, 65 collagen excretion, 108
Osteoclast formation and, 261 Vertebra
Tumoral calcinosis Hyperphosphatemic tumoral calcinosis
Hyperphosphatemic, vertebral and, 316 X-ray
involvement in, 316 Vitamin D receptor Botulism toxin-related osteoporosis
Immunosorbent assay for measurement analysis, 72
of, 319
Ultrasound, quantitative
Bone mineral density analysis, age, Women, postmenopausal Zoledronate
gender, and fragility fracture effects, Bone mass, insulin-like growth factor-| Type II collagen breakdown in Paget’s
118 and leptin influence on, 113 disease of bone, 461